Evidence map›Paper›PMID 34970906›Full record

ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2021

[Research status and prospect of artificial intelligence technology in the diagnosis of urinary system tumors].

Kun Liu, Mingyang Zhang, Haoran Li, Xianghui Wang, Dongming Li, Shuang Liu, Kun Yang, Zhenduo Sun, Linyan Xue, Zhenyu Cui

Open access · greenAbstract read
In one paragraph

Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. [Feature distillation multiple instance learning method based on sequence reorganized Mamba].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kun LiuSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Mingyang ZhangSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Haoran LiSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Xianghui WangSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Dongming LiDepartment of Urology, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R.China.
Shuang LiuSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Kun YangSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Zhenduo SunSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Linyan XueSchool of Quality and Technical Supervision, Hebei University, Baoding, Hebei 071002, P.R.China.
Zhenyu CuiDepartment of Urology, Affiliated Hospital of Hebei University, Baoding, Hebei 071000, P.R.China.
Hebei University · CNAffiliated Hospital of Hebei University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid development of artificial intelligence technology, researchers have applied it to the diagnosis of various tumors in the urinary system in recent years, and have obtained many valuable research results. The article sorted the research status of artificial intelligence technology in the fields of renal tumors, bladder tumors and prostate tumors from three aspects: the number of papers, image data, and clinical tasks. The purpose is to summarize and analyze the research status and find new valuable research ideas in the future. The results show that the artificial intelligence model based on medical data such as digital imaging and pathological images is effective in completing basic diagnosis of urinary system tumors, image segmentation of tumor infiltration areas or specific organs, gene mutation prediction and prognostic effect prediction, but most of the models for the requirement of clinical application still need to be improved. On the one hand, it is necessary to further improve the detection, classification, segmentation and other performance of the core algorithm. On the other hand, it is necessary to integrate more standardized medical databases to effectively improve the diagnostic accuracy of artificial intelligence models and make it play greater clinical value.

Indexed as

Artificial IntelligenceProstatic NeoplasmsAlgorithmsHumansMalePrognosisTechnologyartificial intelligencebladder cancerprostate cancerrenal cell carcinomaurinary system

Identifiers

PMID34970906
PMCPMC9927132
OpenAlexW4205107991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.